At US_FDA's request, Allergan is recalling all of its Biocell textured breast implants to protect women from the risk of breast implant–associated anaplastic large cell lymphoma.
) and encouraging patients and health care professionals to report adverse events to the agency. This voluntary recall is a direct result of the agency’s comprehensive efforts to improve the quality of data collected and analyzed, and the FDA’s ongoing work to evaluate all available safety information.
Textured breast implants overall are less common in the U.S. compared to other countries and specifically, macro-textured implants represent less than 5% of all breast implants sold in the U.S. Although this type of textured breast implant may represent a small proportion of the U.S. market, the continued availability of Allergan BIOCELL textured breast implants pose a public health risk to patients.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA requests recall of Allergan textured breast implants linked to cancerJUST IN: In a major reversal, FDA now says they are asking breast implant maker Allergan to recall its textured implants after the agency found a higher risk of cancer linked to those devices.
Read more »
FDA asks Allergan to recall textured breast implants worldwideAllergan Plc said on Wednesday it was recalling its Biocell textured breast impl...
Read more »
Allergan Recalls Breast Implants After FDA Cites Lymphoma LinkAllergan recalled certain textured breast implants from the market after U.S. health regulators said there was an increase in cases of a rare type of cancer and deaths among women receiving the implants.
Read more »
Allergan Issues Worldwide Recall of Textured Breast ImplantsThe recall was requested by the FDA due to the risk of a type of cancer.
Read more »
FDA Enlists Street Magician to Stop Kids From VapingIf there’s one thing cool teens respect, it’s an adult who has devoted their life to the craft of street magic
Read more »
FDA launches new campaign against e-cigarettesThe U.S. Food and Drug Administration launched a new campaign, 'The Real Cost,' which aims to reach more than 10 million young people who are at risk for picking up e-cig
Read more »